With the enforcement of the European Directive 2011/62/EU relating to medicinal products for human use regarding falsified medicinal products, new requirements are introduced for active substances. The new regulation requires among other things, documentation of the supply chain traceability.
With the enforcement of the European Directive 2011/62/EU relating to medicinal products for human use regarding falsified medicinal products, new requirements are introduced for active substances. The new regulation requires among other things, documentation of the supply chain traceability.
When purchasing from FeF Chemicals, you are purchasing from a European company based in Denmark. All the manufacturing activities are located in Denmark at our facility in Koege.
From 1st of March FeF Chemicals was registered as a manufacturer of Active Substances at the Danish Health and Medicines Authority.
The supply chain at FeF Chemicals is fully traceable and you need neither to be concerned about APIs imported from non-EU countries, nor to get a written confirmation from a competent authority in foreign countries.
Do not hesitate to contact us if you have questions or require more information.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.